Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Elena Böhles has worked on the following 80 EPO patent applications which have been published in the last five years:

EP11753834

FtsZ INHIBITORS AS POTENTIATORS OF BETA-LACTAM ANTIBIOTICS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS

IPC classification:
A01N 25/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11753836

BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS

IPC classification:
A61K 38/00, A61K 38/12, A61K 38/14
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12198385

Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition

IPC classification:
A61K 9/20, A61K 31/513, A61K 31/517, A61P 31/18
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12811874

METHOD FOR PURIFYING FC-FUSION PROTEIN

IPC classification:
C07K 1/18, C07K 1/22, C07K 16/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12811245

METHOD FOR DETECTION OF AMYLOID BETA OLIGOMERS IN A FLUID SAMPLE AND USES THEREOF

IPC classification:
G01N 21/76, G01N 33/53
Applicant:
Merck & Co. Inc.
Agent:
Maura O'Connell, F. R. Kelly & Co.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12825540

CRYSTAL FORMS OF A HCV PROTEASE INHIBITOR

IPC classification:
A61K 38/12
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825726

METHODS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
A01N 43/04, A01N 43/42, A61K 31/44, A61K 31/70
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12821921

N-GLYCOSYLATED INSULIN ANALOGUES

IPC classification:
A61K 38/28, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11766546

PRODRUGS OF AN HIV REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A61K 31/44, C07D 471/02
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12834491

CELL SURFACE DISPLAY OF LIGANDS FOR THE INSULIN AND/OR INSULIN GROWTH FACTOR 1 RECEPTOR AND APPLICATIONS THEREOF

IPC classification:
C40B 40/02, G01N 33/567, G01N 33/569
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843508

ENGINEERED LOWER EUKARYOTIC HOST STRAINS FOR RECOMBINANT PROTEIN EXPRESSION

IPC classification:
C07H 21/04, C12N 15/09
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12843872

CONTROLLING O-GLYCOSYLATION IN LOWER EUKARYOTES

IPC classification:
C12N 1/00, C12N 15/00, C12P 21/06
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12844827

BIOMARKERS FOR TSLP TREATMENT

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12846590

METHODS OF PREPARING LYOPHILIZED SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12846186

CHROMATOGRAPHY PROCESS FOR RESOLVING HETEROGENEOUS ANTIBODY AGGREGATES

IPC classification:
B01D 15/08, C07K 16/00, C12P 21/08
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP12846655

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS SA2074 PROTEIN

IPC classification:
C07K 14/31
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12845161

METHOD FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12811568

IL-23 ANTAGONISTS FOR TREATMENT OR PREVENTION OF SKIN RASH ASSOCIATED WITH TREATMENT WITH P13K/AKT PATHWAY INHIBITORS

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12849080

Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING

IPC classification:
C12P 21/08
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12846671

ENGINEERED PICHIA STRAINS WITH IMPROVED FERMENTATION YIELD AND N-GLYCOSYLATION QUALITY

IPC classification:
C12N 15/00, C12P 21/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12859353

PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS

IPC classification:
A61K 39/104, C07K 14/21, C07K 16/12
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13740509

VACCINES AGAINST CLOSTRIDIUM DIFFICILE COMPRISING RECOMBINANT TOXINS

IPC classification:
C07K 14/33
Applicant:
Intervet International BV
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13749326

METHODS FOR REDUCING MANNOSYLTRANSFERASE ACTIVITY IN YEAST

IPC classification:
C12N 1/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12826404

PROCESS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
A01N 43/04, A01N 43/42, A61K 31/44, A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12810612

5'-SUBSTITUTED NUCLEOSIDE ANALOGS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/415, C07H 19/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12811164

5'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/415, C07H 19/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12802183

HPV VACCINE FORMULATIONS COMPRISING ALUMINUM ADJUVANT AND METHODS OF PRODUCING SAME

IPC classification:
A61K 9/00, A61K 9/19, A61K 39/00, A61K 39/12, A61K 47/02, A61K 47/18, A61K 47/26, C12N 15/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13763727

STABLE PEPTIDE MIMETICS OF THE HIV-1 GP41 PRE-HAIRPIN INTERMEDIATE

IPC classification:
A61K 38/00, A61K 39/21, C12N 7/00, G01N 33/53
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13769724

1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/439, A61P 31/04, C07D 471/08
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769389

ISOXAZOLE beta-LACTAMASE INHIBITORS

IPC classification:
A61K 31/46, A61P 31/00, C07D 451/06
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12823625

USE OF INORGANIC MATRIX AND ORGANIC POLYMER COMBINATIONS FOR PREPARING STABLE AMORPHOUS DISPERSIONS

IPC classification:
A61K 9/10, A61K 9/14, A61K 31/277, A61K 31/405, A61K 31/437, A61K 31/444, A61K 31/496, A61K 47/02, A61K 47/38
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13778279

BIOMARKERS FOR MONITORING INTERVENTION THERAPIES FOR DIABETES

IPC classification:
A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13787435

SURFACE ANCHORED LIGHT CHAIN BAIT ANTIBODY DISPLAY SYSTEM

IPC classification:
C40B 30/04
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13770320

IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13748245

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A61K 31/343, A61K 31/407, A61P 1/16, A61P 31/14, C07D 491/107
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13854963

LIQUID FORMULATIONS FOR TNFR:FC FUSION PROTEINS

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13861070

O-GLYCOSYLATED CARBOXY TERMINAL PORTION (CTP) PEPTIDE-BASED INSULIN AND INSULIN ANALOGUES

IPC classification:
A61K 38/28
Applicant:
Merck & Co. Inc.
Applicant:
Indiana University Research and Technology Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13858630

IMPROVED CULTIVATION MEDIA AND PROCESS FOR IMPROVED PROTEIN PRODUCTION BY PICHIA STRAINS

IPC classification:
C12P 21/00
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13863050

ENGINEERED LOWER EUKARYOTIC HOST STRAINS DEFICIENT IN GRR1 ACTIVITY FOR RECOMBINANT PROTEIN EXPRESSION

IPC classification:
C12N 1/19
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13862934

MEDICATION INJECTOR WITH NEAR-EMPTY ALERT

IPC classification:
A61M 5/315
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864587

PROCESS FOR PURIFYING INSULIN AND ANALOGUES THEREOF

IPC classification:
A61K 38/28, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13861823

LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Agent:
Michelle O'Neill, Harrison IP Limited
Status:
APPLICATION WITHDRAWN
EP13863785

PMT2, OCH1, PMT5 MUTANT CELLS

IPC classification:
C12N 15/52, C12N 15/63
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13865827

DUAL CHAMBER MIXING SYRINGES AND METHODS OF USING SAME

IPC classification:
A61M 5/32
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13814812

ANTIBODIES THAT BIND TO HUMAN PROGRAMMED DEATH LIGAND 1 (PD-L1)

IPC classification:
C07K 16/28, G01N 33/574, G01N 33/577
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13864159

BIOMARKERS FOR PSORIASIS TREATMENT RESPONSE

IPC classification:
A61P 17/06, C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13863926

ON-COLUMN REFOLDING AND PURIFYING OF LIPOPROTEINS

IPC classification:
C07K 14/775
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP15166643

ILT3 BINDING MOLECULES AND USES THEREFOR

IPC classification:
A61K 39/00, A61K 39/395, C07K 14/705, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13865458

LIQUID FORMULATIONS FOR AN ANTI-TNF ALPHA ANTIBODY

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14749562

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14748737

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A01N 43/00, A61K 31/397
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14752178

METHODS FOR INCREASING N-GLYCAN OCCUPANCY AND REDUCING PRODUCTION OF HYBRID N-GLYCANS IN PICHIA PASTORIS STRAINS LACKING ALG3 EXPRESSION

IPC classification:
A61K 38/16, C07K 9/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14775102

ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS

IPC classification:
C12N 5/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14778739

IMMUNOHISTOCHEMICAL ASSAY FOR DETECTING EXPRESSION OF PROGRAMMED DEATH LIGAND 1 (PD-L1) IN TUMOR TISSUE

IPC classification:
G01N 33/53
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11761856

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/4439, A61P 31/18, C07D 401/06
Applicant:
Merck Canada Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14810345

PREPARATION OF TERT-BUTYL 4-((1R,2S,5R)-6- (BENZYLOXY)-7-0X0-1,6-DIAZABICYCL0[3.2.I]OCTANE-2- CARBOXAMIDO)PIPERIDINE-1-CARBOXYLATE

IPC classification:
C07D 211/00, C07D 491/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14814205

DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/12, A61K 39/193
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP15196341

ANTI-GITR ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14836140

METHODS AND COMPOSITIONS FOR CO-EXPRESSION OF POLYPEPTIDES OF INTEREST AND IL6

IPC classification:
C12N 5/02, C12N 5/07, C12N 15/00, C12N 15/87
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14837218

TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB

IPC classification:
A01N 43/90, A61K 39/395, C07K 14/475, C07K 16/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14761460

MODULATION OF TUMOR IMMUNITY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14854507

METHOD OF OBTAINING THERMOSTABLE DRIED VACCINE FORMULATIONS

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854498

THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS

IPC classification:
A61K 9/19, A61K 39/12, A61P 31/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854464

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C07K 1/36
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11707763

FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/695, A61P 31/14, C07F 7/08
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14870360

IMMUNOHISTOCHEMICAL PROXIMITY ASSAY FOR PD-1 POSITIVE CELLS AND PD-LIGAND POSITIVE CELLS IN TUMOR TISSUE

IPC classification:
A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872286

IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15740828

METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/41, A61K 31/4184, C07D 257/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15761797

PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE

IPC classification:
A61K 38/00, A61K 38/28, C07K 1/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15773458

PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES

IPC classification:
A61K 47/24
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15789928

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/192, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15824392

CHROMATOGRAPHY PROCESS FOR PURIFICATION OF INLSULIN AND INSULIN ANALOGS

IPC classification:
A61K 38/28, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15830117

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/357
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829663

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/192, A61K 31/353, C07D 311/20
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15829695

[7,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS

IPC classification:
A61K 31/192, A61K 31/34, A61K 31/343, A61K 31/44, A61K 31/47, C07D 215/16, C07D 215/20, C07D 307/80, C07D 409/12, C07D 413/00, C07D 493/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753872

ANTI-TIGIT ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/02, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753877

ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

IPC classification:
A61K 39/00, A61K 39/395, A61P 37/02, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15753363

METHODS OF TREATING LYMPHOMA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517, A61P 35/00
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15836281

METHOD FOR PREPARING CRYSTALLINE INSULIN OR INSULIN ANALOG COMPOSITIONS

IPC classification:
A61K 38/28, A61K 47/02, C07K 1/32, C07K 14/62
Applicant:
Merck & Co. Inc.
Agent:
Elena Böhles, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature